These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19449873)

  • 1. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity.
    Nakagawa Y; Yanagita RC; Hamada N; Murakami A; Takahashi H; Saito N; Nagai H; Irie K
    J Am Chem Soc; 2009 Jun; 131(22):7573-9. PubMed ID: 19449873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
    Irie K; Yanagita RC; Nakagawa Y
    Med Res Rev; 2012 May; 32(3):518-35. PubMed ID: 22539107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin.
    Irie K; Yanagita RC
    Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activity.
    Yanagita RC; Kamachi H; Tanaka K; Murakami A; Nakagawa Y; Tokuda H; Nagai H; Irie K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6064-6. PubMed ID: 20817520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
    Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the Phenolic Hydroxyl Group and Aromaticity from the Side Chain of Anti-Proliferative 10-Methyl-aplog-1, a Simplified Analog of Aplysiatoxin, Enhances Its Tumor-Promoting and Proinflammatory Activities.
    Hanaki Y; Kikumori M; Tokuda H; Okamura M; Dan S; Adachi N; Saito N; Yanagita RC; Irie K
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28406454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.
    Kikumori M; Yanagita RC; Tokuda H; Suzuki N; Nagai H; Suenaga K; Irie K
    J Med Chem; 2012 Jun; 55(11):5614-26. PubMed ID: 22625994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of the amide derivative of aplog-1, a simplified analog of aplysiatoxin with anti-proliferative and cytotoxic activities.
    Hanaki Y; Yanagita RC; Sugahara T; Aida M; Tokuda H; Suzuki N; Irie K
    Biosci Biotechnol Biochem; 2015; 79(6):888-95. PubMed ID: 25612633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective versus tumorigenic protein kinase C activators.
    Nelson TJ; Alkon DL
    Trends Biochem Sci; 2009 Mar; 34(3):136-45. PubMed ID: 19233655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.
    Basu A; Kozikowski AP; Sato K; Lazo JS
    Cancer Res; 1991 May; 51(10):2511-4. PubMed ID: 2021930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.
    Berkow RL; Schlabach L; Dodson R; Benjamin WH; Pettit GR; Rustagi P; Kraft AS
    Cancer Res; 1993 Jun; 53(12):2810-5. PubMed ID: 8504423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein kinase C isozymes involved in the anti-proliferative and pro-apoptotic activities of 10-Methyl-aplog-1, a simplified analog of debromoaplysiatoxin, in several cancer cell lines.
    Hanaki Y; Shikata Y; Kikumori M; Hotta N; Imoto M; Irie K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):438-445. PubMed ID: 29129688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial analogs of naturally occurring tumor promoters as biochemical tools and therapeutic leads.
    Nakagawa Y
    Biosci Biotechnol Biochem; 2012; 76(7):1262-74. PubMed ID: 22785480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies on the side chain of a simplified analog of aplysiatoxin (aplog-1) with anti-proliferative activity.
    Kamachi H; Tanaka K; Yanagita RC; Murakami A; Murakami K; Tokuda H; Suzuki N; Nakagawa Y; Irie K
    Bioorg Med Chem; 2013 May; 21(10):2695-702. PubMed ID: 23582444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.
    Ashida Y; Yanagita RC; Takahashi C; Kawanami Y; Irie K
    Bioorg Med Chem; 2016 Sep; 24(18):4218-4227. PubMed ID: 27436807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP.
    Baryza JL; Brenner SE; Craske ML; Meyer T; Wender PA
    Chem Biol; 2004 Sep; 11(9):1261-7. PubMed ID: 15380186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
    J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori activates protein kinase C delta to control Raf in MAP kinase signalling: role in AGS epithelial cell scattering and elongation.
    Brandt S; Wessler S; Hartig R; Backert S
    Cell Motil Cytoskeleton; 2009 Oct; 66(10):874-92. PubMed ID: 19437514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG; Grunicke D; Drexler HG
    Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor promoter receptor protein kinase C: a novel target for chemoprevention and therapy of human colon cancer.
    O'Brian CA; Ward NE; Gravitt KR; Gupta KP
    Prog Clin Biol Res; 1995; 391():117-20. PubMed ID: 8532710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.